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Abstract
Objectives: Many studies have shown laparoscopic distal pancreatectomy (LDP) to have benefits over
open distal pancreatectomy (ODP). This institution made a unique abrupt transition from an exclusively
open approach to a preference for the laparoscopic technique. This study aimed to compare outcomes
in patients undergoing LDP and ODP, respectively, over the period of transition.
Methods: A retrospective review of all patients undergoing LDP (n = 82) or ODP (n = 90) was performed.
Surrogate oncologic markers for the subgroup of patients with malignant disease were also studied.
Results: The ODP and LDP groups were well matched with regard to demographics, comorbidities and
tumour characteristics. Significant differences were noted in favour of the LDP group in which decreases
were seen in estimated blood loss (<0.001), need for packed red blood cell transfusions (<0.001), length
of hospital stay (<0.001) and intensive care unit stay (<0.001). No other significant differences in the
occurrence of complications or oncologic outcomes were seen. Rates of Grade B and C fistulae were
10% and 6% in the ODP and LDP groups, respectively. Grade III–V complications occurred in 20% and
13% of the ODP and LDP groups, respectively.
Conclusions: Laparoscopic distal pancreatectomy continues to compare favourably with ODP when
well-matched patient series are reviewed. The results show a decreased need for blood transfusions and
hospital resources in LDP. Additionally, there may be oncologic advantages associated with LDP com-
pared with ODP in pancreatic malignancies.
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Introduction
Recent advances in the field of minimal-access surgery have
resulted in the increasing acceptance of the laparoscopic approach
to distal pancreas resection over the past decade. Many early pub-
lications have shown the feasibility of the procedure1–5 and
described the technique of distal pancreatectomy.6–8 Smaller
single-institution series have shown the laparoscopic approach to
offer significant advantages compared with the open approach,
but only four of these series reported over 50 patients in the
laparoscopic group.9–12 More recently, comparative meta-analyses
comprising larger groups of patients over multiple institutions
have demonstrated that the laparoscopic approach is safe and
results in significant improvements in hospital stay and morbidity
compared with its open counterpart.13–15 Other series have looked
at the oncologic aspects of laparoscopic distal pancreatectomy
(LDP) and have found it to have acceptable outcomes compared
with open distal pancreatectomy (ODP).16 Despite this, a recent
look at administrative database information on the use of lapar-
oscopy in the resection of lesions in the body or tail of the pan-
creas implies that LDP is widely underutilized across the USA.17
The fundamental goal of any change in surgical technique is to
improve outcomes. For those undergoing surgery for benign
disease, the goal of surgery is to decrease morbidity, recovery time
and the occurrence of complications. For those with malignant
disease, improved surgery would ideally maintain or enhance
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oncologic results, including longterm survival. Because of its
recent introduction and the short follow-up associated with LDP,
no longterm studies are available. However, multiple studies have
analysed operative variables in pancreatic and peripancreatic
malignancies that serve as markers of improved cancer outcomes,
including decreased operative blood loss,18 decreased lymph node
ratio,19 and negative resection (R0) margin status.20
This study reports a comparison of a single institution’s expe-
rience in distal pancreatectomy prior to and after the introduction
of the laparoscopic approach without the need for a learning
curve. Clinical outcomes were analysed to assess any differences
between the LDP and ODP groups. Additionally, surrogate
markers of oncologic outcomes were compared to assess the non-
inferiority of the minimal-access approach and to establish
whether LDP might offer any advantages over ODP for patients
with pancreatic malignancies.
Materials and methods
Patients and data collection
A review of all patients undergoing distal pancreatic resection at a
tertiary academic centre between January 2005 and December
2011 was performed. All patient data were collected from a com-
prehensive retrospective and prospective pancreatic resection
database which included clinical, operative and pathologic infor-
mation on all patients undergoing pancreatic resection. Distal
pancreas resection was defined as any resection of the pancreas
parenchyma starting at the neck or distal to the neck with or
without splenectomy and included subtotal resections up to the
level of the gastroduodenal artery and superior mesenteric vein.
All surgical procedures carried out at this high-volume hepato-
pancreaticobiliary centre over this 7-year period were performed
by surgeons with significant experience in pancreatic surgery.
Prior to August 2008, 99% (74/75) of all distal pancreatic resec-
tions were performed using an open technique. Between August
2008 (from the arrival of the senior author, HJA) and the end of
the study time period, only 17% (16/97) of distal pancreatic resec-
tions were performed using an open technique.
Preoperative variables examined included patient age, gender,
body mass index (BMI), comorbidities, Eastern Cooperative
Oncology Group (ECOG) status and American Society of
Anesthesiologists (ASA) class. Operative data included estimated
intraoperative blood loss (EBL; ml), operative time (min), total
packed red blood cells (pRBC; units) transfused during the opera-
tion or in the subsequent hospitalization, intensive care unit (ICU;
days) stay required, total length of stay (LoS; days) including the
days of operation and discharge, and discharge destination.
Definitions
Data on inpatient and 30-day postoperative complications were
collected and scored according to the Clavien–Dindo complica-
tion scale.21 Complications of Grades I and II were considered
minor; those of Grades III–V were considered major. Pancreatic
fistula,22 delayed gastric emptying23 and post-pancreatectomy
haemorrhage24 were defined according to the International Study
Group of Pancreatic Surgery (ISGPS) definitions.
Subgroup analysis was performed for those patients who
underwent ODP or LDP for pancreatic adenocarcinoma and
pancreatic neuroendocrine tumours (PNETs). This analysis was
performed to examine oncologic data including tumour size
(maximum dimension, cm), total number of lymph nodes,
number of positive lymph nodes, lymph node ratio (in N1
patients only), tumour–node (TN) stage and margin status.
Margin analysis was performed in each specimen in a radial
fashion and an R1 resection was defined as the microscopic pres-
ence of tumour cells at any margin.
Operative technique
The steps and technique used in LDP have been previously pub-
lished.6 Briefly, the patient is positioned in a slight right lateral
decubitus position. Initial abdominal access is gained through an
abdominal Hasson trocar and three additional trocars are placed
(Fig. 1). The steps of the operation proceed in a clockwise fashion:
the splenic flexure of the colon is taken down first to obtain
complete mobilization of the distal transverse and proximal
descending colon from the tail of the pancreas. The gastrocolic
ligament is incised, completely exposing the tail of the pancreas. If
a splenectomy is to be performed, the gastrosplenic ligament and
Figure 1 Diagram showing abdominal access in laparoscopic distal
pancreatectomy through an abdominal Hasson trocar and three
additional trocars
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short gastric vessels are transected up to the superior pole of the
spleen. Then, an appropriate transection site on the pancreas is
chosen, often with the aid of intraoperative ultrasound. Parenchy-
mal transection is accomplished with an endoscopic stapling
device with staple line reinforcement material using a slow, step-
wise compression technique. Splenic vasculature is either ligated
en bloc for pancreatic transection sites away from the coeliac
trunk or separately when the level of the parenchymal transection
site is in proximity or to the right of the coeliac trunk. The distal
pancreas is then elevated and transected from the retroperito-
neum, spleen mobilization is completed if splenectomy is per-
formed, and the specimen is placed into a retrieval bag and
removed through the umbilical trocar site. The spleen is usually
morselized in a piecemeal fashion within an endoscopic retrieval
bag. Jackson–Pratt drains are occasionally placed in the operative
bed at the discretion of the surgeon.
In ODP, the steps used varied among surgeons, but the proce-
dure was generally performed through a left subcostal incision
using standard techniques. Parenchymal transection was accom-
plished with staplers and individual pancreatic duct ligation in
most patients. Splenic vasculature ligation was generally accom-
plished separately from parenchymal transection.
Statistical analysis
Descriptive data are reported as medians and ranges to summarize
continuous variables, or as frequencies and proportions for cat-
egorical data. Continuous data were compared using Wilcoxon
signed-rank test analysis; categorical data were analysed using the
Fisher’s exact test or Cochran–Armitage trend test as appropriate.
The statistical significance of between-group differences was
assumed at a P-value of <0.05. All calculations were performed
using sas Version 9.2 (SAS Institute, Inc., Cary, NC, USA).
Research ethics board approval
Appropriate approval to conduct this retrospective review was
obtained through the Mayo Clinic Internal Review Board.
Results
Patient demographics
In the study time period, a total of 172 patients underwent distal
pancreatectomy at the study institution. Open and laparoscopic
distal pancreatectomies were performed in 90 (52%) and 82
(48%) patients, respectively. Table 1 gives patient information
including age, sex, BMI, comorbidities, ECOG and ASA status for
the two groups. No significant differences in any of these param-
eters were found between the groups.
Operations and indications
Data on pancreatic resection procedures and indications for
surgery are given in Table 2. All patients undergoing completion
distal pancreatectomy were operated on an elective basis. Intraop-
erative conversion to a hand-assisted method or to an open
approach was required in nine (11%) and six (7%) patients,
respectively, and was generally performed for significant inflam-
mation, adhesions or the close proximity of tumour to the coeliac
trunk.
Additional abdominal procedures were performed in 28 (31%)
and 18 (22%) patients undergoing ODP and LDP, respectively
(P = 0.227). These were most commonly cholecystectomy, partial
gastrectomy, partial colectomy, adrenalectomy and nephrectomy.
Operative variables and complications
Table 3 gives data on operative variables and complications in the
LDP and ODP groups. Forty (44%) patients undergoing ODP and
10 (12%) patients undergoing LDP required at least one unit of
pRBC during the operation or subsequent hospitalization (P <
0.001). Overall morbidity and mortality were similar in the LDP
and ODP groups. Clinically significant pancreatic fistula (Grades
B and C) occurred in 10% and 6% of patients in the ODP and
LDP groups, respectively. Major complications (Grades III–V)
occurred in 20% and 13% of patients in the ODP and LDP
groups, respectively.
Two patients in each group required reoperation. Both patients
in the ODP group underwent reoperation to control acute arterial
haemorrhage. Reoperations in patients in the LDP group included
Table 1 Patient demographics and comorbidities
Open surgery
group
(n = 90, 52%)
Laparoscopic
group
(n = 82, 48%)
P-value
Gender, n (%) 0.486
Male 35 (39) 33 (40)
Female 55 (61) 49 (60)
Hypertension, n (%) 48 (53) 47 (57) 0.652
Diabetes mellitus, n
(%)
23 (26) 19 (23) 0.731
Cardiac disease, n
(%)
23 (26) 18 (23) 0.603
Pulmonary disease,
n (%)
25 (28) 20 (24) 0.732
ECOG grade, n (%) 0.344
0 63 (70) 63 (77)
1 25 (28) 17 (21)
2 1 (1) 2 (3)
3 1 (1) 0
ASA class, n (%) 0.140
2 19 (21) 22 (27)
3 65 (72) 59 (72)
4 6 (7) 1 (1)
Age, years, median
(range)
64 (28–85) 65 (17–89) 0.448
BMI, kg/m2, median
(range)
27.7 (17.2–62.5) 26.8 (17.4–50.8) 0.616
ECOG, Eastern Cooperative Oncology Group; ASA, American Society of
Anesthesiologists; BMI, body mass index.
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one for a postoperative haematoma evacuation and one for fascial
dehiscence at the umbilical site used for specimen extraction.
Oncologic outcomes
Subgroup analysis of oncologic outcomes in patients undergoing
ODP or LDP for pancreatic adenocarcinoma or PNET is given in
Table 4. Tumour size, TN stage, number of positive lymph nodes,
total lymph node harvest, lymph node ratio and margin status did
not differ significantly between the two groups.
Discussion
Over the past decade, substantial evidence for the feasibility and
safety of the laparoscopic approach in resections of the left-sided
pancreas has emerged. In addition, recent meta-analyses per-
formed on the world literature13–15 have demonstrated significant
advantages over the open approach. Despite this, a recent look at
administrative databases shows that LDP appears to be substan-
tially underused across the USA.17 At the reporting institution, the
technique of LDP was not introduced until August 2008, with the
arrival of the senior author. Prior to this, with the exception of one
patient, all distal pancreatic resections had been performed using
an open technique. From August 2008, only 16 (17%) of 97 distal
pancreatic resections were performed using an open approach.
Eight of these ODPs in the more recent period were performed for
benign disease in the presence of severe inflammation that pre-
cluded laparoscopic dissection. The other half were performed for
malignant disease that involved large bulky tumours or significant
prior upper abdominal surgery or multivisceral organ resection.
To the authors’ knowledge, there have been only four compara-
tive series with more than 50 patients.9–12 This study analyses the
changes in outcomes when a surgeon with prior expertise in the
procedure introduced LDP into a well-established open pancre-
atic practice at a tertiary teaching institution. Hence, the data are
not affected by a learning curve. There were no differences in
patient demographics, comorbidities, BMI or underlying pathol-
ogy among patients undergoing either approach over the whole
study period. No differences were anticipated because referral
patterns were stable over the course of the study period and the
transition from an exclusively open approach to a minimally inva-
sive approach in the majority of patients implies the absence of
any significant selection bias. However, it is conceivable that a
potential selection bias might emerge over a longer study period
and in a larger patient sample.However, it is unclear which patient
group would be affected by such a bias because patients who
required ODP in the more recent period of the study were often
younger (mean age: 56.6 years versus 62.5 years; P = 0.121) and
more often had benign chronic pancreatitis (50% versus 11%; P =
0.001) compared with patients undergoing ODP in the earlier part
of the study period. Furthermore, the greatest advantages of LDP
are often seen in patients of advanced age, higher BMI and with
more comorbidities. However, it is clear that patients who under-
went ODP in the more recent period were at greater risk for
complications either because the magnitude of surgery was
greater or because of the presence of chronic pancreatitis or more
advanced tumour characteristics, such as attachment to the
coeliac trunk or encasement of the superior mesenteric–portal
vein trunk. Non-statistically relevant increases in major morbid-
ity, EBL and operative time were observed in the 16 patients who
underwent ODP after August 2008 compared with those who
underwent ODP in the earlier part of the study period. Rates of
pancreatic fistula (31% versus 11%; P = 0.048),mean pRBC trans-
fusions (4.9 units versus 2.0 units; P = 0.022) and mean LoS (9.4
days versus 7.8 days; P = 0.035) were significantly higher in ODP
patients in the more recent period compared with the overall
group of ODP patients in the earlier part of the study period.
A higher rate of splenic preservation was seen in patients
undergoing LDP in this series, similarly to that seen in a Korean
study.9 Although much of this discrepancy can be attributed to
differences in the individual management and aggressiveness of
splenic salvage among surgeons performing distal pancreatec-
tomy, the authors feel that splenic vessel preservation is much
easier under the magnification afforded by laparoscopy. The
underlying indications for ODP and LDP did not change
throughout the study period and therefore do not represent a
cause for this difference.
Overall hospital LoS and ICU utilization were significantly
lowered by the use of LDP. Pulmonary complications were also
lower in LDP, but operative time, overall morbidity and the occur-
rence of pancreatic fistula were not significantly affected by the
approach. A tendency towards a rate of decreased fistula in LDP
was nevertheless noted. The 6% rate of fistulae of Grades B and C
compares favourably with rates reported in the majority of the
literature.14,15 Although a definitive conclusion cannot be drawn
Table 2 Type of resection and pathology
Open
surgery
group
(n = 90, 52%)
Laparoscopic
group
(n = 82, 48%)
P-value
Surgical approach, n (%)
Distal 88 (98) 81 (99) 1.0
Completion distal 2 (2) 1 (1) 1.0
Splenic preservation 2 (2) 10 (12) 0.013
Pathology, n (%)
Pancreatic
adenocarcinoma
21 (23) 18 (22) 1.0
IPMN 21 (23) 18 (22) 1.0
PNET 13 (14) 13 (16) 1.0
Benign/chronic
pancreatitis
15 (17) 13 (16) 1.0
Cystic neoplasm 12 (13) 14 (17) 1.0
Miscellaneous solid
neoplasm
8 (9) 6 (7) 1.0
IPMN, intraductal pancreatic mucinous neoplasm; PNET, pancreatic neu-
roendocrine tumour.
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from this particular study, it may be that this lower rate is attrib-
utable to the specific technique of stapled division using slow
compression, as previously described.6
Estimated blood loss and transfusion requirements in patients
undergoing LDP were dramatically lower than in patients under-
going ODP over the study period. As the two groups were similar
in underlying indications and other patient comparison measure-
ments, it appears that this disparity is almost entirely related to
the differences between ODP and LDP in dissection technique.
Laparoscopic distal pancreatectomy is associated with more
precise dissection performed under magnification using a ‘no-
touch’ technique. The tumour is generally not manipulated and
the vasculature is surrounded and transected early in the proce-
dure using a right-to-left approach. Additionally, the short gastric
vessels and diaphragmatic attachments of the spleen are all con-
trolled under direct visualization during LDP, which is not always
possible in ODP.
Comparisons of oncologic outcomes in patients undergoing
LDP and ODP, respectively, for pancreatic adenocarcinoma or
PNET were analysed to assess whether there was any compromise
in the extent of oncologic resection in the laparoscopic approach.
Laparoscopic distal pancreatectomy is still used selectively by
some surgeons at other institutions who consider the presence of
malignancy as a contraindication to laparoscopy. The comparison
Table 3 Operative variables and complications
Open surgery group
(n = 90, 52%)
Laparoscopic group
(n = 82, 48%)
P-value
Estimated blood loss, ml, median (range) 500 (25–5000) 70 (5–1500) <0.001
Operative time, min, median (range) 233 (55–568) 188 (83–405) 0.431
pRBCs during hospitalization, units, median (range) 0 (0–24) 0 (0–2) <0.001
ICU stay, days, median (range) 0 (0–5) 0 (0–3) <0.001
Overall length of stay, days, median (range) 8 (3–18) 4 (1–10) <0.001
Cardiac complications, n (%) 10 (11) 3 (4) 0.078
Pulmonary complications, n (%) 13 (14) 4 (5) 0.042
Reoperation, n (%) 2 (2) 2 (2) 1.0
Pancreatic fistula (overall), n (%) 13 (14) 11 (13) 1.0
Fistula grade, n (%) 0.213
Grade A 4 (4) 6 (7)
Grade B 1 (1) 1 (1)
Grade C 8 (9) 4 (5)
Post-pancreatectomy haemorrhage (overall), n (%) 3 (3) 1 (1) 0.624
Haemorrhage grade, n (%) 0.357
Grade A 2 (2) 0
Grade B 1 (1) 0
Grade C 1 (1) 1 (1)
Delayed gastric emptying rate, n (%) 4 (4) 0 0.122
Wound infection, n (%) 5 (6) 2 (2) 0.447
Intra-abdominal abscess, n (%) 5 (6) 4 (5) 1.0
Clavien–Dindo complications (30-day/inpatient), n (%) 0.987
Minor, n (%) Grade I 15 (17) 11 (14)
Moderate, n (%) Grade II 20 (22) 5 (6)
Severe, n (%) Grades III–V 18 (20) 11 (13)
Grade IIIa 13 (14) 6 (7)
Grade IIIb 2 (2) 3 (4)
Grade IVa 1 (1) 2 (3)
Grade IVb 1 (1) 0
Grade V 1 (1) 0
Discharged to: 0.193
Home, n (%) 85 (94) 80 (98)
Facility, n (%) 5 (6) 2 (2)
pRBC, packed red blood cells; ICU, intensive care unit.
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showed a smaller tumour size, but a higher total lymph node
harvest and lower lymph node ratio in patients undergoing LDP.
However, none of these differences reached statistical significance.
Tumour stage, nodal status andmargins were also similar between
the groups. Longterm outcomes for LDP are not yet available, but
surrogate markers for improved survival, including need for blood
transfusion, lymph node harvest and ratio, and margin status
show that the LDP approach is at the least not inferior to ODP and
may even provide benefits in patients undergoing distal pancreatic
resection for malignancy. Strasberg et al.25 have pointed out that
modification of the dissection plane to the posterior of the adrenal
gland and Gerota’s fascia, also known as posterior radical ante-
grade modular pancreatosplenectomy (RAMPS), will occasionally
be necessary to achieve negative tangential margins in carcinoma
of the body or tail of the pancreas in order to obtain satisfactory
survival rates. Although the procedures reported by Strasberg
et al.25 were performed using an open approach, the present
authors believe that this modification can be readily performed
when completing LDP. In fact, four patients undergoing LDP for
malignancy (13%) underwent a successful RAMPS for tumours
extending posteriorly into this plane. None of the conversions
were performed for this reason, although one patient required
conversion for close tumour involvement of the coeliac trunk
vessels.
At present, the evidence for the treatment of pancreatic malig-
nancy of the body and tail, namely adenocarcinoma, using LDP
remains uncertain. Nonetheless, the present authors consider that
a bloodless, margin-negative resection with adequate or improved
peripancreatic lymph node harvest is attainable using this
approach and that the presence of malignancy should not con-
traindicate its use. However, as previously reported,6 one patient
was found to have a trocar site recurrence 2 months after under-
going an uncomplicated LDP. The recurrence was successfully
excised and the patient remained disease-free for >1 year, but
suffered eventual disease recurrence and died at 23 months. Long-
term follow-up with matched comparisons are required before
any definitive conclusions on differences in survival for pancreatic
malignancy can be made.
At present, it appears that there is enough evidence in the
literature to postulate that LDP should play a more standard role
and should be considered as the procedure of choice in distal
pancreatic resection. An open procedure, however, may still be
preferred for selected patients, particularly in the presence of sig-
nificant chronic inflammation or a large lesion in direct proximity
to the coeliac trunk.
Conclusions
This series suggests that the laparoscopic approach can be safely
introduced into an experienced open pancreatic practice without
negative effect when there is no need for a learning curve. As in
other studies, the advantages of the laparoscopic approach relate
to decreases in blood loss, number of transfusions required, hos-
pital LoS and time to overall recovery. Findings for other out-
comes tended to favour LDP, but no significant differences
emerged between the procedures except in the rate of pulmonary
complications. Oncologic principles as measured by surrogate
markers appear not to be compromised and, in fact, some were
improved in the laparoscopic group. However, longterm survival
data and larger series are required to support any definitive con-
clusions on the potential advantages of the laparoscopic approach
in patients with cancer.
Conflicts of interest
None declared.
References
1. Fernandez-Cruz L, Cosa R, Blanco L, Levi S, Lopez-Boado MA, Navarro
S. (2007) Curative laparoscopic resection for pancreatic neoplasms: a
critical analysis from a single institution. J Gastrointest Surg 11:1607–
1621; discussion 1621–1622.
2. Kooby DA, Gillespie T, Bentrem D, Nakeeb A, Schmidt MC, Merchant NB
et al. (2008) Left-sided pancreatectomy: a multicentre comparison of
laparoscopic and open approaches. Ann Surg 248:438–446.
Table 4 Oncologic outcomes in patients with pancreatic adeno-
carcinoma and neuroendocrine tumours undergoing distal
pancreatectomy
Open
surgery
group
(n = 34, 38%)
Laparoscopic
group
(n = 31, 38%)
P-value
Tumour size, cm,
median (range)
2.8 (0.5–15) 2 (0.5–7.5) 0.247
Positive lymph nodes,
n, median (range)
0 (0–6) 0 (0–9) 0.793
Total lymph nodes,
n, median (range)
11 (1–45) 16.5 (0–48) 0.152
Lymph node ratio
(N1 patients only),
median (range)
0.130
(0.030–0.670)
0.120
(0.020–0.250)
0.888
Tumour stage, n (%) 1.0
T1 7 (21) 12 (40)
T2 3 (9) 3 (10)
T3 18 (53) 14 (47)
T4 1 (3) 0
Unknown 5 (15) 1 (3)
Node stage, n (%) 0.779
N0 21 (62) 23 (74)
N1 10 (29) 8 (26)
Unknown 3 (9) 0
Surgical margin, n (%)
R0 32 (94) 30 (97) 1.0
R1 2 (6) 1 (3)
154 HPB
HPB 2013, 15, 149–155 © 2012 International Hepato-Pancreato-Biliary Association
3. Melotti G, Butturini G, Piccoli M, Casetti L, Bassi C, Mullineris B et al.
(2007) Laparoscopic distal pancreatectomy: results on a consecutive
series of 58 patients. Ann Surg 246:77–82.
4. Palanivelu C, Shetty R, Jani K, Sendhilkumar K, Rajan PS,
Maheshkumar GS. (2007) Laparoscopic distal pancreatectomy: results
of a prospective non-randomized study from a tertiary centre. Surg
Endosc 21:373–377.
5. Mabrut JY, Fernandez-Cruz L, Azagra JS, Bassi C, Delvaux G, Weerts J
et al. (2005) Laparoscopic pancreatic resection: results of a multicentre
European study of 127 patients. Surgery 137:597–605.
6. Asbun HJ, Stauffer JA. (2011) Laparoscopic approach to distal and
subtotal pancreatectomy: a clockwise technique. Surg Endosc 25:2643–
2649.
7. Fernandez-Cruz L. (2006) Distal pancreatic resection: technical differ-
ences between open and laparoscopic approaches. HPB 8:49–56.
8. Subhas G, Gupta N, Mittal VK, Jacobs MJ. (2011) Laparoscopic three-
port distal pancreatectomy. HPB 13:361–363.
9. Kim SC, Park KT, Hwang JW, Shin HC, Lee SS, Seo DW et al. (2008)
Comparative analysis of clinical outcomes for laparoscopic distal pan-
creatic resection and open distal pancreatic resection at a single institu-
tion. Surg Endosc 22:2261–2268.
10. DiNorcia J, Schrope BA, Lee MK, Reavey PL, Rosen SJ, Lee JA
et al. (2010) Laparoscopic distal pancreatectomy offers shorter
hospital stays with fewer complications. J Gastrointest Surg 14:1804–
1812.
11. Vijan SS, Ahmed KA, Harmsen WS, Que FG, Reid-Lombardo KM,
Nagorney DM et al. (2010) Laparoscopic vs. open distal pancreatectomy:
a single-institution comparative study. Arch Surg 145:616–621.
12. Jayaraman S, Gonen M, Brennan MF, D'Angelica MI, DeMatteo RP, Fong
Y et al. (2010) Laparoscopic distal pancreatectomy: evolution of a tech-
nique at a single institution. J Am Coll Surg 211:503–509.
13. Venkat R, Edil BH, Schulick RD, Lidor AO, Makary MA, Wolfgang CL.
(2012) Laparoscopic distal pancreatectomy is associated with signifi-
cantly less overall morbidity compared to the open technique: a system-
atic review and meta-analysis. Ann Surg 255:1048–1059.
14. Xie K, Zhu YP, Xu XW, Chen K, Yan JF, Mou YP. (2012) Laparoscopic
distal pancreatectomy is as safe and feasible as open procedure: a
meta-analysis. World J Gastroenterol 18:1959–1967.
15. Jusoh AC, Ammori BJ. (2012) Laparoscopic versus open distal pancrea-
tectomy: a systematic review of comparative studies. Surg Endosc
26:904–913.
16. Kooby DA, Hawkins WG, Schmidt CM, Weber SM, Bentrem DJ, Gillespie
TW et al. (2010) A multicentre analysis of distal pancreatectomy for
adenocarcinoma: is laparoscopic resection appropriate? J Am Coll Surg
210:779–785; discussion 786–787.
17. Rosales-Velderrain A, Bowers SP, Goldberg RF, Clarke TM, Buchanan
MA, Stauffer JA et al. (2012) National trends in resection of the distal
pancreas. World J Gastroenterol 18:4342–4349.
18. Nagai S, Fujii T, Kodera Y, Kanda M, Sahin TT, Kanzaki A et al. (2011)
Impact of operative blood loss on survival in invasive ductal adenocar-
cinoma of the pancreas. Pancreas 40:3–9.
19. Pawlik TM, Gleisner AL, Cameron JL, Winter JM, Assumpcao L, Lillemoe
KD et al. (2007) Prognostic relevance of lymph node ratio following pan-
creaticoduodenectomy for pancreatic cancer. Surgery 141:610–618.
20. Howard TJ, Krug JE, Yu J, Zyromski NJ, Schmidt CM, Jacobson LE et al.
(2006) A margin-negative R0 resection accomplished with minimal post-
operative complications is the surgeon's contribution to longterm survival
in pancreatic cancer. J Gastrointest Surg 10:1338–1345; discussion
1345–1346.
21. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD
et al. (2009) The Clavien–Dindo classification of surgical complications:
five-year experience. Ann Surg 250:187–196.
22. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J et al. (2005)
Postoperative pancreatic fistula: an international study group (ISGPF)
definition. Surgery 138:8–13.
23. Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR et al.
(2007) Delayed gastric emptying (DGE) after pancreatic surgery: a sug-
gested definition by the International Study Group of Pancreatic Surgery
(ISGPS). Surgery 142:761–768.
24. Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ et al.
(2007) Post-pancreatectomy haemorrhage (PPH): an International Study
Group of Pancreatic Surgery (ISGPS) definition. Surgery 142:20–25.
25. Strasberg SM, Linehan DC, Hawkins WG. (2007) Radical antegrade
modular pancreatosplenectomy procedure for adenocarcinoma of
the body and tail of the pancreas: ability to obtain negative tangential
margins. J Am Coll Surg 204:244–249.
HPB 155
HPB 2013, 15, 149–155 © 2012 International Hepato-Pancreato-Biliary Association
